Professional Summary
Professional Overview
Douglas Dew is an accomplished healthcare executive and academic leader with extensive expertise in artificial intelligence, cognitive healthcare, and next-generation expert systems. As the Co-Founder and CEO of Automated Clinical Guidelines, LLC, he drives the development of innovative AI-powered solutions to improve clinical decision-making and patient outcomes. Additionally, he serves as a Professor of Orthopaedic Surgery at the University of Central Florida, contributing his deep knowledge and insights to the next generation of healthcare professionals.
Experience Summary
Current Roles
- Co-Founder and CEO, Automated Clinical Guidelines, LLC (2006-Present): Responsible for the strategic vision and operational leadership of the company, which specializes in designing and deploying AI-driven clinical decision support systems. Under his guidance, the company has become a recognized leader in the field, with a focus on improving the efficiency and accuracy of clinical guidelines and recommendations.
- Professor of Orthopaedic Surgery, University of Central Florida (2014-Present): Brings his extensive clinical and research expertise to the classroom, educating and inspiring the next generation of healthcare professionals. Actively engaged in shaping the curriculum and advancing the university's reputation in orthopaedic care.
- Faculty Lecturer, A.I., Cognitive Healthcare, Data Forums, and Next Generation Expert Systems (2013-Present): Leverages his deep understanding of emerging technologies to deliver insightful lectures and participate in panel discussions at various industry events and forums.
- Maryland Health Services Cost Review Commission's Technical Advisory Panel (TAP), Maryland Health Services Cost Review Commission (HSCRC) (2025-Present): Serves as a key technical advisor, providing valuable insights and recommendations to the commission on healthcare cost management and policy.
- Fellow, American Academy of Orthopaedic Surgeons (2012-Present): Recognized for his contributions to the field of orthopaedic surgery, he has been elected to the prestigious Board of Councilors, where he helps shape the academy's strategic direction and initiatives.
Career Progression
Prior to his current roles, Douglas Dew held various academic and research positions, including adjunct faculty roles at leading institutions such as Johns Hopkins University and the University of Maryland. His early career was marked by his clinical practice in orthopaedic surgery, where he gained hands-on experience and developed a deep understanding of the challenges facing the healthcare industry.
Academic Background
Douglas Dew holds a Medical Degree (M.D.) from the University of Florida, where he also completed his residency in Orthopaedic Surgery. He is a recognized expert in his field, with a strong focus on applying emerging technologies, such as artificial intelligence and cognitive computing, to enhance clinical decision-making and improve patient outcomes.
Areas of Expertise
- Artificial Intelligence in Healthcare
- Cognitive Computing and Decision Support Systems
- Clinical Guideline Development and Implementation
- Orthopaedic Surgery and Patient Care
- Healthcare Cost Management and Policy
- Academic Leadership and Curriculum Development
Professional Impact
Throughout his career, Douglas Dew has made significant contributions to the healthcare industry. As the Co-Founder and CEO of Automated Clinical Guidelines, LLC, he has led the development of cutting-edge AI-powered solutions that have been adopted by leading healthcare organizations, improving the efficiency and accuracy of clinical decision-making. In his academic roles, he has been instrumental in shaping the curriculum and advancing the university's reputation in orthopaedic care, while also serving as a trusted advisor to the Maryland Health Services Cost Review Commission on healthcare cost management and policy.
Conclusion
With his extensive experience, deep expertise, and unwavering commitment to innovation, Douglas Dew is poised to continue making a lasting impact on the healthcare industry. His strategic vision, technical acumen, and collaborative leadership style make him a valuable asset in driving the adoption of transformative technologies and improving patient outcomes.
